Emicizumab in people with moderate or mild haemophilia AHAVEN 6 a multicentre open label singlearm phase 3 study

C NegrierJohnny MahlanguM LehleP ChowdaryOlivier CatalaniE et al2024-07-232024-07-23WOS2352-3026https://hdl.handle.net/10539/39120Emicizumab in people with moderate or mild haemophilia AHAVEN 6 a multicentre open label singlearm phase 3 studyJournal Article